Matches in Nanopublications for { ?s ?p "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP679054.RAiGyRrKduNUoClCmafiGCCkLWuiIGwsbHntSC-8hTTOE130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679054.RAiGyRrKduNUoClCmafiGCCkLWuiIGwsbHntSC-8hTTOE130_provenance.
- NP874437.RAjM0RrtqLI7Rwie8vl0ZATBZxbs3brEvfFGJgUpkAON8130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874437.RAjM0RrtqLI7Rwie8vl0ZATBZxbs3brEvfFGJgUpkAON8130_provenance.
- NP552368.RAo7YSis4E6ZFLfsakAW4btMQhnpuv5AOS7zcxlD_07ws130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552368.RAo7YSis4E6ZFLfsakAW4btMQhnpuv5AOS7zcxlD_07ws130_provenance.
- NP836809.RAtuycXeIne02Hu3Nz_9CWI0ln97hj3GHbxmUbWRwjNVo130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836809.RAtuycXeIne02Hu3Nz_9CWI0ln97hj3GHbxmUbWRwjNVo130_provenance.
- NP533590.RA5U2EgkG-VsUBJnvQtHxQM7u9vl8XdmdRkxpHiPzOeB0130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP533590.RA5U2EgkG-VsUBJnvQtHxQM7u9vl8XdmdRkxpHiPzOeB0130_provenance.
- NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP192692.RA6hMRqiCl-EM67Y4k9tK8o_JK8o_WSLDDTCiV9zABRks130_provenance.
- NP477987.RAPzkI5uveLSaYmWh3O8T6o_POGV8ICCacg2V_5K9X2vI130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477987.RAPzkI5uveLSaYmWh3O8T6o_POGV8ICCacg2V_5K9X2vI130_provenance.
- NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518259.RAK-9LF0IiHqLesBqma1dgnsE9LHdl39ds11pyTqbxdhA130_provenance.
- NP741351.RAHwq9D6YeAGSZ0jNyLW6J89JkJBG83ZiiGmQDh6Uu7Sg130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP741351.RAHwq9D6YeAGSZ0jNyLW6J89JkJBG83ZiiGmQDh6Uu7Sg130_provenance.
- assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_provenance.
- NP978510.RAqaMUDw-O-aL8gnuFoXVnT5-JGi05mfZ9HZ7flbexDFk130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978510.RAqaMUDw-O-aL8gnuFoXVnT5-JGi05mfZ9HZ7flbexDFk130_provenance.
- NP1006497.RAqn9mbBP21VdN358jQNpG9H1ujd3d-qUIgeXwG1HGv70130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006497.RAqn9mbBP21VdN358jQNpG9H1ujd3d-qUIgeXwG1HGv70130_provenance.
- NP978583.RA6xhaVgIpgSv-8JFtE4A61K_GLlGz79Y4tqfiFi7Vf90130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978583.RA6xhaVgIpgSv-8JFtE4A61K_GLlGz79Y4tqfiFi7Vf90130_provenance.